Humoral responses to independent vaccinations are correlated in healthy boosted adults

Vaccine

Volumn 32, Issue 43, 2014, Pages 5624-5631

  Garman, Lori ^a,b   Vineyard, Amanda J ^a   Crowe, Sherry R ^a,f   Harley, John B ^c,d   Spooner, Christina E ^e   Collins, Limone C ^e   Nelson, Michael R ^e   Engler, Renata J M ^e   James, Judith A ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e WALTER REED ARMY MEDICAL CENTER   (United States)

^f PharmAthene Inc   (United States)

Author keywords

Anthrax vaccine adsorbed; Hepatitis B; Measles; Mumps; Pertussis; Tetanus

Indexed keywords

ANTHRAX VACCINE; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MEASLES ANTIBODY; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; RUBELLA ANTIBODY; RUBELLA VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; BACTERIUM ANTIBODY; VIRUS ANTIBODY;

ADULT; ANTHRAX; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HALF LIFE TIME; HEPATITIS B; HUMAN; HUMORAL IMMUNITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; MUMPS; PERTUSSIS; RACE; RUBELLA; SEROCONVERSION; SOLDIER; TETANUS; TETANUS PROPHYLAXIS; VACCINATION; ANTIBODY PRODUCTION; BLOOD; IMMUNIZATION; IMMUNOLOGY; STATISTICS AND NUMERICAL DATA; WHOOPING COUGH; YOUNG ADULT;

ADULT; ANTHRAX; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY FORMATION; FEMALE; HEPATITIS B; HUMANS; IMMUNIZATION, SECONDARY; MALE; MEASLES; MILITARY PERSONNEL; MUMPS; TETANUS; VACCINATION; WHOOPING COUGH; YOUNG ADULT;

EID: 84908458684     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.005     Document Type: Article

References (46)

1. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008, 8:1659-1667.
2. Shapiro E.D. Acellular vaccines and resurgence of pertussis. JAMA 2012, 308:2149-2150.
3. Cherry J.D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005, 115:1422-1427.
4. Centers for Disease C, Prevention Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older-United States, 2013. Morb Mortal Wkly Rep Surveill Summ 2013, 62(Suppl 1:1).
5. Centers for Disease, C., Prevention Noninfluenza vaccination coverage among adults-United States, 2011. MMWR Morb Mortal Wkly Rep 2013, 62:66-72.
6. Grabenstein J.D., Pittman P.R., Greenwood J.T., Engler R.J. Immunization to protect the US Armed Forces: heritage, current practice, and prospects. Epidemiol Rev 2006, 28:3-26.
7. St Sauver J.L., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Green E.M., Schaid D.J., et al. Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school children. Vaccine 2001, 19:1363-1368.
8. Westmoreland D., Player V., Heap D.C., Hammond A. Immunization against hepatitis B-what can we expect? Results of a survey of antibody response to immunization in persons 'at risk' of occupational exposure to hepatitis B. Epidemiol infect 1990, 104:499-509.
9. Heron L.G., Chant K.G., Jalaludin B.B. A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart. Vaccine 2002, 20:3472-3476.
10. Cherry J.D. Why do pertussis vaccines fail. Pediatrics 2012, 129:968-970.
11. Marano N., Plikaytis B.D., Martin S.W., Rose C., Semenova V.A., Martin S.K., et al. Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial. JAMA 2008, 300:1532-1543.
12. Tetanus, vaccine. Wkly Epidemiol Rec 2006; 81:198-208.
13. Crowe S.R., Ash L.L., Engler R.J., Ballard J.D., Harley J.B., Farris A.D., et al. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. J Infect Dis 2010, 202:251-260.
14. Crowe S.R., Garman L., Engler R.J., Farris A.D., Ballard J.D., Harley J.B., et al. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine 2011, 29:3670-3678.
15. Jacobson R.M., Poland G.A. The genetic basis for measles vaccine failure. Acta Paediatr Suppl 2004, 93:43-46. discussion 6-7.
16. Ceyhan M., Kanra G., Erdem G., Kanra B. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Vaccine 2001, 19:4473-4478.
17. Desombere I., Willems A., Leroux-Roels G. Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998, 51:593-604.
18. Alper C.A., Kruskall M.S., Marcus-Bagley D., Craven D.E., Katz A.J., Brink S.J., et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989, 321:708-712.
19. Kennedy R.B., Ovsyannikova I.G., Haralambieva I.H., O'Byrne M.M., Jacobson R.M., Pankratz V.S., et al. Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine 2012, 30:2159-2167.
20. Lu J., He R., Dong M., Zhang L., Wang X. Immunological dynamics in response to two anthrax vaccines in mice. Sci China, Ser C Life Sci 2008, 51:872-878.
21. Davila S., Froeling F.E., Tan A., Bonnard C., Boland G.J., Snippe H., et al. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun 2010, 11:232-238.
22. Burns V.E., Drayson M., Ring C., Carroll D. Perceived stress and psychological well-being are associated with antibody status after meningitis C conjugate vaccination. Psychosom Med 2002, 64:963-970.
23. Edwards K.M., Burns V.E., Adkins A.E., Carroll D., Drayson M., Ring C. Meningococcal A vaccination response is enhanced by acute stress in men. Psychosom Med 2008, 70:147-151.
24. Brydon L., Walker C., Wawrzyniak A.J., Chart H., Steptoe A. Dispositional optimism and stress-induced changes in immunity and negative mood. Brain Behav Immun 2009, 23:810-816.
25. Hollinger F.B. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 1989, 87:36S-40S.
26. Pebody R.G., Gay N.J., Hesketh L.M., Vyse A., Morgan-Capner P., Brown D.W., et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002, 20:1134-1140.
27. Quinn C.P., Semenova V.A., Elie C.M., Romero-Steiner S., Greene C., Li H., et al. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002, 8:1103-1110.
28. Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17:1055-1065.
29. Quinn C.P., Sabourin C.L., Niemuth N.A., Li H., Semenova V.A., Rudge T.L., et al. A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques. Clin Vaccine Immunol 2012, 19:1730-1745.
30. Amanna I.J., Carlson N.E., Slifka M.K. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007, 357:1903-1915.
31. Edelman K., He Q., Makinen J., Sahlberg A., Haanpera M., Schuerman L., et al. Immunity to pertussis 5 years after booster immunization during adolescence. Clin Infect Dis 2007, 44:1271-1277.
32. Brunell P.A., Weigle K., Murphy M.D., Shehab Z., Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983, 250:1409-1412.
33. Hutchins S.S., Bellini W.J., Coronado V., Jiles R., Wooten K., Deladisma A. Population immunity to measles in the United States, 1999. J Infect Dis 2004, 189(Suppl 1):S91-S97.
34. Hainz U., Jenewein B., Asch E., Pfeiffer K.P., Berger P., Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005, 23:3232-3235.
35. Montefiori D.C., Metch B., McElrath M.J., Self S., Weinhold K.J., Corey L. Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. J Infect Dis 2004, 190:1962-1969.
36. Gardner E.M., Gonzalez E.W., Nogusa S., Murasko D.M. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 2006, 24:1609-1614.
37. Christy C., Pichichero M.E., Reed G.F., Decker M.D., Anderson E.L., Rennels M.B., et al. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics 1995, 96:584-587.
38. Engler R.J., Nelson M.R., Klote M.M., VanRaden M.J., Huang C.Y., Cox N.J., et al. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Arch Intern Med 2008, 168:2405-2414.
39. Phillips A.C., Gallagher S., Carroll D., Drayson M. Preliminary evidence that morning vaccination is associated with an enhanced antibody response in men. Psychophysiology 2008, 45:663-666.
40. Centers for Disease, C., Prevention Measles-United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:253-257.
41. Zipprich J., Hacke J.K., Murray E.L., Xia D., Harriman K., Glase C., et al. Notes from the field: measles-California, January 1-April 18, 2014. MMWR Morb Mortal Wkly Rep 2014, 63:362-363.
42. Skoff T.H., Cohn A.C., Clark T.A., Messonnier N.E., Martin S.W. Early Impact of the US Tdap vaccination program on pertussis trends. Arch Pediatr Adolesc Med 2012, 166:344-349.
43. Pajewski N.M., Parker S.D., Poland G.A., Ovsyannikova I.G., Song W., Zhang K., et al. The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun 2011, 12:457-465.
44. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., Poland G.A. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 2005, 191:515-519.
45. Li Y., Ni R., Song W., Shao W., Shrestha S., Ahmad S., et al. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet 2009, 126:685-696.
46. Pan L., Zhang W., Liang Z., Wu X., Zhu X., Li J., et al. Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J Med Virol 2012, 84:26-33.